Business Description
Bangkok Genomics Innovation PCL
ISIN : THB972010003
Description
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 19.28 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.33 | |||||
| Interest Coverage | 33.36 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 13.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.4 | |||||
| 3-Year EBITDA Growth Rate | 32.1 | |||||
| 3-Year EPS without NRI Growth Rate | 32.9 | |||||
| 3-Year FCF Growth Rate | 83.4 | |||||
| 3-Year Book Growth Rate | 75.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.19 | |||||
| 9-Day RSI | 46.18 | |||||
| 14-Day RSI | 43.34 | |||||
| 6-1 Month Momentum % | -17.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.59 | |||||
| Quick Ratio | 10.07 | |||||
| Cash Ratio | 8.31 | |||||
| Days Inventory | 38.87 | |||||
| Days Sales Outstanding | 51.86 | |||||
| Days Payable | 46.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -19.79 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.94 | |||||
| Operating Margin % | 15.61 | |||||
| Net Margin % | 15.01 | |||||
| FCF Margin % | -5.2 | |||||
| ROE % | 10.07 | |||||
| ROA % | 8.82 | |||||
| ROIC % | 35.07 | |||||
| ROC (Joel Greenblatt) % | 44.53 | |||||
| ROCE % | 10.01 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.86 | |||||
| PE Ratio without NRI | 29.86 | |||||
| Price-to-Owner-Earnings | 26.46 | |||||
| PS Ratio | 4.03 | |||||
| PB Ratio | 2.42 | |||||
| Price-to-Tangible-Book | 2.44 | |||||
| EV-to-EBIT | 19.38 | |||||
| EV-to-EBITDA | 14.22 | |||||
| EV-to-Revenue | 3.03 | |||||
| EV-to-FCF | -58.17 | |||||
| Price-to-Graham-Number | 1.8 | |||||
| Price-to-Net-Current-Asset-Value | 2.9 | |||||
| Price-to-Net-Cash | 3.85 | |||||
| Earnings Yield (Greenblatt) % | 5.16 | |||||
| FCF Yield % | -1.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bangkok Genomics Innovation PCL Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 296.39 | ||
| EPS (TTM) (฿) | 0.071 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 43.34 | ||
| 14-Day ATR (฿) | 0.116851 | ||
| 20-Day SMA (฿) | 2.1865 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (฿) | 1.67 - 5.65 | ||
| Shares Outstanding (Mil) | 600 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bangkok Genomics Innovation PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bangkok Genomics Innovation PCL Stock Events
| Event | Date | Price(฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bangkok Genomics Innovation PCL Frequently Asked Questions
What is Bangkok Genomics Innovation PCL(BKK:BKGI)'s stock price today?
The current price of BKK:BKGI is ฿2.12. The 52 week high of BKK:BKGI is ฿5.65 and 52 week low is ฿1.67.
When is next earnings date of Bangkok Genomics Innovation PCL(BKK:BKGI)?
The next earnings date of Bangkok Genomics Innovation PCL(BKK:BKGI) is .
Does Bangkok Genomics Innovation PCL(BKK:BKGI) pay dividends? If so, how much?
Bangkok Genomics Innovation PCL(BKK:BKGI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers